STOCK TITAN

Enfusion, Inc. - ENFN STOCK NEWS

Welcome to our dedicated page for Enfusion news (Ticker: ENFN), a resource for investors and traders seeking the latest updates and insights on Enfusion stock.

Enfusion, Inc. (symbol: ENFN) is a pioneering provider of cloud-based portfolio management and risk systems, headquartered in Chicago, Illinois. With branch offices in New York, as well as wholly-owned subsidiaries in London and Hong Kong, Enfusion stands at the forefront of delivering innovative solutions to clients within the financial services industry. Their advanced software as a service (SaaS) platform empowers investment managers by unifying mission-critical systems and providing a single dataset for real-time performance, risk calculations, and accounting of complex financial products.

Enfusion's core business revolves around transforming the investment management industry by eliminating technology and information barriers, allowing investment managers to make informed decisions swiftly and efficiently. The company's solutions simplify investment and operational workflows, coalescing data into a single source of truth. This integrated approach helps clients manage over $90 billion in assets across some of the world's largest and most respected hedge funds.

Enfusion's recent achievements highlight its exceptional growth trajectory. The company has expanded its operations significantly, with maximum revenue generation from the Americas, followed by Asia Pacific and Europe, the Middle East, and Africa. Their innovative platform is trusted by numerous global clients for its real-time performance and robust risk management capabilities.

Enfusion continues to innovate and refine its offerings. Some of their current projects include enhancing their cloud-based solutions to further streamline investment processes and improve data accuracy. The company also emphasizes strong partnerships and collaboration with other industry leaders to bring the latest technological advancements to their clients.

Financially, Enfusion is on solid footing, experiencing rapid growth and affirming its position as a leader in the investment management software industry. The company's client base spans across the globe, relying on Enfusion's cutting-edge solutions to navigate the complexities of financial management.

Overall, Enfusion, Inc. is a crucial player in the financial services industry, known for its commitment to innovation, client satisfaction, and delivering value through state-of-the-art technology.

Rhea-AI Summary

ConnexPay, a leader in payments technology, has secured a $110 million growth equity investment led by FTV Capital. This funding will facilitate ConnexPay's expansion into new verticals and geographies, building on a remarkable 500% net revenue growth year-to-date 2022. The company, founded in 2017, serves various industries including travel and fintechs, and has doubled its active clients in the past year. With this latest round, ConnexPay’s total funding reaches $145 million. The investment will also support continued technology enhancements and the hiring of key staff for global expansion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.57%
Tags
none
-
Rhea-AI Summary

Enfusion, Inc. (NYSE: ENFN) will release its third quarter fiscal year 2022 financial results on November 10, 2022, after U.S. markets close. A conference call will follow at 5:00 PM ET, where management will discuss the results and provide business performance insights and financial guidance. Investors and interested parties can access the call by dialing (844) 200-6205 domestically or (929) 526-1599 internationally, with a conference ID of 826984. A live webcast will be available on the company’s Investor Relations page.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.9%
Tags
-
Rhea-AI Summary

Enfusion (NYSE: ENFN) has partnered with Apex Group to enhance middle-office services for global fund administrators. This collaboration will leverage Enfusion's SaaS platform for cash and position reconciliation, trade affirmation, and more, aimed at improving operational efficiency and reducing costs for Apex's clients. Enfusion's software is now actively supporting five fund managers in the Asia-Pacific region. This partnership reflects a strategic move to expand Enfusion's reach beyond traditional markets and integrate advanced technology into Apex's offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.85%
Tags
none
Rhea-AI Summary

FTV Capital has been recognized for the second consecutive year on Inc.’s Founder-Friendly Investors list. This accolade highlights its effective support for entrepreneurs, following significant milestones including closing its largest fund at $2.3 billion in March 2022. Over the past twelve months, FTV reported $1.1 billion in liquidity events and deployed over $900 million. The firm has a strong portfolio of over 130 companies and utilizes a robust network to foster growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.02%
Tags
none
-
Rhea-AI Summary

Enfusion has been ranked #78 on the 2022 IDC FinTech Rankings, advancing from #86 last year. This annual ranking recognizes top global financial technology providers based on revenues from the financial services sector. The report highlights Enfusion's commitment to delivering innovative, cloud-native SaaS solutions for investment management. Oleg Movchan, Interim CEO, emphasized the company's dedication to simplifying investment operations while enhancing client experiences. Global IT spending in the financial services sector is projected to reach $590 billion by 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.47%
Tags
none
-
Rhea-AI Summary

Patra Corporation has secured a $146 million growth equity investment from FTV Capital, aimed at expanding its customer reach and enhancing automation within the insurance industry. With 16 consecutive years of revenue growth, Patra addresses critical challenges in the $60 billion U.S. insurance market, including an aging workforce and rising operational costs. This funding will facilitate market expansion and technology deployment across its services, leveraging Patra's proprietary PatraOne platform. FTV's expertise in tech-enabled services will support Patra's future product offerings and customer value delivery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.47%
Tags
none
Rhea-AI Summary

Enfusion, Inc. (NYSE: ENFN) has appointed Oleg Movchan as Interim CEO, effective August 21, 2022, succeeding Thomas Kim, who resigned to focus on family. Movchan brings over 25 years of experience in investment management, having served on the Board for over a decade. The company continues to experience strong demand for its investment management software, reiterating its 2022 revenue guidance despite anticipated costs related to the CEO transition affecting Adjusted EBITDA.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.44%
Tags
management
-
Rhea-AI Summary

Enfusion, a leader in cloud-based investment management software, reported a 38% year-over-year revenue growth, reaching $36.5 million for Q2 2022. Despite strong performance, the company posted a net loss of $(4.1) million, impacted by $7.7 million in stock-based compensation. Adjusted EBITDA was $5.4 million, with an adjusted margin of 14.9%. Notably, the Net Dollar Retention Rate improved to 121.9%. The company added 50 new clients, bringing the total to 793, and introduced Enfusion Express for smaller fund managers. Guidance for Q3 is $38-$39 million in revenue.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.61%
Tags
none
-
Rhea-AI Summary

Enfusion, Inc. (NYSE: ENFN) has launched Enfusion Express, a SaaS order and execution management system aimed at smaller fund managers with less than $100 million in assets under management. This new product intends to address the operational needs of this underserved market segment by providing enhanced pre-trade, execution, and post-trade solutions. Cowen has partnered with Enfusion as the first distributor of this service, aiming to deliver comprehensive support to its clients, while BroadArch Capital becomes the initial client using Enfusion Express.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.19%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.19%
Tags
none

FAQ

What is the current stock price of Enfusion (ENFN)?

The current stock price of Enfusion (ENFN) is $8.895 as of October 31, 2024.

What is the market cap of Enfusion (ENFN)?

The market cap of Enfusion (ENFN) is approximately 836.6M.

What does Enfusion, Inc. do?

Enfusion, Inc. provides cloud-based portfolio management and risk systems for the financial services industry.

Where is Enfusion headquartered?

Enfusion is headquartered in Chicago, Illinois.

What is Enfusion's core business focus?

Enfusion focuses on transforming the investment management industry by eliminating technology and information barriers.

How much in assets do Enfusion's clients manage?

Enfusion's clients manage over $90 billion in assets.

In which regions does Enfusion generate the most revenue?

Enfusion generates the most revenue from the Americas, followed by Asia Pacific and EMEA regions.

What recent achievements has Enfusion made?

Enfusion has seen exceptional growth and expanded its global operations significantly.

What kind of clients does Enfusion serve?

Enfusion serves global clients, including some of the world’s largest and most respected hedge funds.

How does Enfusion simplify investment and operational workflows?

Enfusion simplifies workflows by unifying mission-critical systems and providing a single dataset for accurate data management.

What are some current projects Enfusion is working on?

Enfusion is working on enhancing cloud-based solutions to streamline investment processes and improve data accuracy.

What is Enfusion's market position?

Enfusion is a leader in the financial services industry, known for its commitment to innovation and client satisfaction.

Enfusion, Inc.

NYSE:ENFN

ENFN Rankings

ENFN Stock Data

836.57M
93.21M
6.44%
97.32%
1.63%
Software - Application
Services-prepackaged Software
Link
United States of America
CHICAGO